Evidence map›Paper›PMID 28108191›Full record

ArticleAmerican journal of preventive medicine2017

Use of Electronic Cigarettes Among U.S. Adults With Medical Comorbidities.

Gina R Kruse, Sara Kalkhoran, Nancy A Rigotti

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Electronic Cigarettes and Asthma: What Do We Know So Far?Journal of personalized medicine · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. E-cigarettes and Smoking Cessation in Smokers With Chronic Conditions.American journal of preventive medicine · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gina R KruseDivision of General Internal Medicine, Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;; Harvard Medical School, Boston, Massachusetts. Electronic address: gkruse@mgh.harvard.edu.
Sara KalkhoranDivision of General Internal Medicine, Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;; Harvard Medical School, Boston, Massachusetts.
Nancy A RigottiDivision of General Internal Medicine, Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts;; Harvard Medical School, Boston, Massachusetts.
Harvard University · US

Funding

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized SmokersR01HL111821 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI RIGOTTI, NANCY A, TINDLE, HILARY A. · 2012 to 2021
$8.4M
A Text Messaging Intervention for Smoking Cessation Among Community Health Center PatientsK23DA038717 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI KRUSE, GINA RAE · 2015 to 2019
$975k
NHLBI NIH HHS R01 HL111821NIDA NIH HHS K23 DA038717
6 · The paper itself

Abstract

introductionElectronic cigarette (e-cigarette) use is rising in the U.S. Smokers with comorbidities may increasingly use e-cigarettes if they believe e-cigarettes reduce smoking-related harm. This study examined e-cigarette use among adults with medical comorbidities.

methodsIn 2016, this study analyzed 68,136 U.S. adults in the 2014 and 2015 National Health Interview Survey. Prevalent e-cigarette use by medical comorbidities and adjusted odds of e-cigarette use were calculated.

resultsAmong current cigarette smokers, ever use of e-cigarettes was more often reported by adults with one or more medical comorbidity versus those without comorbidity (18-24 years: 73.5% vs 61.4%; 25-44 years: 60.6% vs 54.3%; 45-64 years: 46.5% vs 40.3%; ≥65 years: 35.2% vs 19.4%; all p<0.05). Current smokers aged 25-64 years with one or more comorbidity reported current e-cigarette use more often than those without comorbidity (25-44 years, 17.8% vs 14.3%, p=0.03; 45-64 years, 15.9% vs 11.5%, p=0.02). Current smokers with chronic obstructive pulmonary disease, asthma, and cardiovascular disease had higher odds of ever e-cigarette use versus those without comorbidity. Current smokers with asthma and cardiovascular disease had higher odds of current e-cigarette use. Former smokers with chronic obstructive pulmonary disease had higher odds of ever and current e-cigarette use and former smokers with cancer had lower odds of current e-cigarette use.

conclusionsE-cigarette use by current and former smokers with medical comorbidities is substantial, especially among individuals with chronic lung or cardiovascular disease. Clinicians should routinely ask these patients about e-cigarette use, actively consider all pathways to help their patients quit combustible cigarettes, and recommend evidence-based treatments.

Indexed as

ComorbidityAdultAgedElectronic Nicotine Delivery SystemsFemaleHealth SurveysHumansMaleMiddle AgedPrevalenceSmokingUnited States

Identifiers

PMID28108191
PMCPMC5438782
OpenAlexW2577306165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.